Ingredion: UBS raises PT to $151 from $149, maintains Neutral rating.

Ingredion: UBS raises PT to $151 from $149, maintains Neutral rating.

UBS has increased its price target for Ingredion (INGR) from $149 to $151, while maintaining a Neutral stance on the stock. This adjustment reflects UBS's updated assessment of Ingredion's market potential. The brokerage firm's analysts believe that the revised target should be considered by investors in their investment strategies.

According to the latest Wall Street analyst forecasts, the average one-year price target for Ingredion is $150.39, with a high estimate of $168.00 and a low estimate of $135.34. This average target implies an upside of 9.99% from the current price of $136.73 [1].

The consensus recommendation from brokerage firms indicates that Ingredion's average brokerage recommendation is currently 2.4, signifying an "Outperform" status. This rating scale ranges from 1 to 5, with 1 representing a Strong Buy and 5 a Sell [1].

GuruFocus estimates the GF Value for Ingredion in one year to be $103.54, suggesting a downside of 24.27% from the current price of $136.73. The GF Value is calculated based on the stock's historical multiples and past business growth estimates [1].

In terms of recent earnings, Ingredion reported net sales of $1.8 billion, down 4% year-over-year. Gross profit increased by 12%, with margins up 350 basis points to 25.7%. Adjusted operating income was $273 million, up 26% year-over-year. The Texture and Healthful Solutions segment experienced a 34% increase in operating income, while the Food and Industrial Ingredients LATAM segment saw a 26% year-over-year increase. Capital expenditures were $92 million, and $55 million of outstanding common shares were repurchased [1].

The company's stock has been the subject of recent institutional buying. Impax Asset Management Group plc acquired a new stake in Ingredion in the first quarter, purchasing 4,780 shares valued at approximately $646,000. Other institutional investors, including BOK Financial Private Wealth Inc., Alpine Bank Wealth Management, Mitsubishi UFJ Asset Management Co. Ltd., Ameriflex Group Inc., and EverSource Wealth Advisors LLC, also made significant purchases in Ingredion's stock [2].

Analysts have also been active in setting new price targets. Wall Street Zen upgraded Ingredion from a "buy" rating to a "strong-buy" rating, while Oppenheimer lowered their price target from $167.00 to $155.00 and set an "outperform" rating. UBS Group set a $155.00 price objective on Ingredion [2].

Ingredion's stock has been performing well, trading up $0.52 to $136.78 on Tuesday, July 2, 2025. The company's 50-day and 200-day simple moving averages are $137.27 and $133.85, respectively. Ingredion has a market capitalization of $8.80 billion, a P/E ratio of 14.43, and a beta of 0.72 [2].

References:
[1] https://www.gurufocus.com/news/2966459/ingredion-ingr-price-target-raised-by-ubs-to-151-ingr-stock-news
[2] https://www.marketbeat.com/instant-alerts/filing-impax-asset-management-group-plc-purchases-new-position-in-ingredion-incorporated-nyseingr-2025-07-07/